These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 11580218
21. Storage at -3 degrees C for 24 h alters the immunogenicity of pertussis vaccines. Boros CA, Hanlon M, Gold MS, Roberton DM. Vaccine; 2001 May 14; 19(25-26):3537-42. PubMed ID: 11348721 [Abstract] [Full Text] [Related]
22. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis. Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB. Clin Infect Dis; 1999 Mar 14; 28(3):552-9. PubMed ID: 10194077 [Abstract] [Full Text] [Related]
23. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis. Morokuma K, Ginnaga A, Nishihara T, Tsunoda S, Furukawa M, Aihara K, Sakoh M. Dev Biol Stand; 1991 Mar 14; 73():223-32. PubMed ID: 1685713 [Abstract] [Full Text] [Related]
24. Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric health-care workers. Littmann M, Hülsse C, Riffelmann M, Wirsing von König CH. Vaccine; 2008 May 02; 26(19):2344-9. PubMed ID: 18396360 [Abstract] [Full Text] [Related]
25. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Hodder SL, Cherry JD, Mortimer EA, Ford AB, Gornbein J, Papp K. Clin Infect Dis; 2000 Jul 02; 31(1):7-14. PubMed ID: 10913389 [Abstract] [Full Text] [Related]
26. Preparation of filamentous hemagglutinin from Bordetella pertussis and assay for serum antibodies to filamentous hemagglutinin and pertussis toxin for clinical and public health laboratories. Wong KH, Skelton SK. J Clin Microbiol; 1989 Dec 02; 27(12):2805-10. PubMed ID: 2556434 [Abstract] [Full Text] [Related]
27. Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015. Barkoff AM, Mertsola J, Pierard D, Dalby T, Hoegh SV, Guillot S, Stefanelli P, van Gent M, Berbers G, Vestrheim D, Greve-Isdahl M, Wehlin L, Ljungman M, Fry NK, Markey K, He Q. Euro Surveill; 2019 Feb 02; 24(7):. PubMed ID: 30782265 [Abstract] [Full Text] [Related]
28. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards KM, Baker CJ. J Infect Dis; 2004 Jul 15; 190(2):335-40. PubMed ID: 15216470 [Abstract] [Full Text] [Related]
36. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis. Ausiello CM, Urbani F, La Sala A, Lande R, Piscitelli A, Cassone A. Dev Biol Stand; 1997 Jul 15; 89():315-20. PubMed ID: 9272365 [Abstract] [Full Text] [Related]
37. Construction and characterization of single-chain variable fragment antibodies directed against the Bordetella pertussis surface adhesins filamentous hemagglutinin and pertactin. Hussein AH, Davis EM, Halperin SA, Lee SF. Infect Immun; 2007 Nov 15; 75(11):5476-82. PubMed ID: 17724067 [Abstract] [Full Text] [Related]
40. Role of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells. van den Berg BM, Beekhuizen H, Mooi FR, van Furth R. Infect Immun; 1999 Mar 15; 67(3):1050-5. PubMed ID: 10024542 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]